BOSTON--(BUSINESS WIRE)--Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel ...
Dr John Leonard from Weill Cornell Medicine in New York reports key findings on diffuse large B-cell lymphoma (DLBCL) presented at ASH 2024. First, Dr Leonard reported on the 5-year POLARIX trial ...
SAN DIEGO — Patients with diffuse large B-cell lymphoma (DLBCL) continue to show superior progression-free survival at 5 years with first-line pola-R-CHP compared with the R-CHOP regimen, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback